Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Bayer Pharma (five hormonal branded products)

M&A STATUS
Buyout/LBO LATEST DEAL TYPE
1 FINANCING ROUNDS
Description

Provider of healthcare services. The business units provides hormone replacement therapy and female contraception. Its products name are Klimonorm, Progynova, Triquilar, Microgynon and Climene.

Ownership Status
Acquired/Merged
Financing Status
Private Equity-Backed
Primary Industry
Other Healthcare Services
Acquirer
Primary Office
  • 51368 Leverkusen
  • Germany

Bayer Pharma (five hormonal branded products) Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Bayer Pharma (five hormonal branded products)‘s full profile, request access.

Request full access to PitchBook

Bayer Pharma (five hormonal branded products) Former Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore Bayer Pharma (five hormonal branded products)‘s full profile, request access.

Request full access to PitchBook